TCL Archive Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer July 31, 2009
TCL Archive Former NIH Director Varmus calls for more oversight of conflicts, expresses surprise at growth of Title 42 program. May 21, 2004
TCL Archive In Brief: NY Judges, Lawyers Form Breast Cancer Alert; Terms of ODAC Chairman, 3 Members Expire July 3, 1992